Fish Based Detection Of Chromosomal Abnormalities From Patients With Hematologic Malignancies

Device Code: 4930

Product Code(s): QDI

Definition: Fluorescence In Situ Hybridization (FISH) Test For Hematologic Malignancies Is Used To Detect Chromosomal Abnormalities In Human Specimens From Patients With Hematologic Malignancies. The Test Is Indicated For The Clinical Management Of Patients Cons

Device Classification Information

Device Type ID4930
Device NameFish Based Detection Of Chromosomal Abnormalities From Patients With Hematologic Malignancies
Physical StateThe Test Kits May Include Fluorescence Labeled DNA Probes, Hybridization Buffers, And A Counterstain
Technical MethodFluorescence In Situ Hybridization
Target AreaHuman Bone Marrow And Peripheral Blood Specimens
Regulation Medical SpecialtyMolecular Genetics
Review PanelPathology
Submission Type510(k)
CFR Regulation Number864.1880 [🔎]
FDA Device ClassificationClass 2 Medical Device
Product CodeQDI
GMP ExemptNo
Summary MRIneligible
Implanted DeviceNo
Life Support DeviceNo
Third Party Review Not Third Party Eligible

Recognized Standards

Total Product Life Cycle

Device Type ID4930
DeviceFish Based Detection Of Chromosomal Abnormalities From Patients With Hematologic Malignancies
Product CodeQDI
FDA Device ClassificationClass 2 Medical Device
CFR Regulation Number864.1880 [🔎]
TPLC Last Update: 2019-04-02 20:57:39

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.